Abbott Q4 results in focus as DOJ probe on baby formula plant looms

Abbott Vascular headquarters in Silicon Valley

Sundry Photography/iStock Editorial via Getty Images

Abbott Laboratories (NYSE:ABT) is scheduled to announce Q4 earnings results on Wednesday, January 25th, before market open.

The consensus EPS Estimate is $0.93 (-29.5% Y/Y) and the consensus Revenue Estimate is $9.69B (-15.7% Y/Y).

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!